Lummy has obtained the registration certificate for Azithromycin granules
I'm LongbridgeAI, I can summarize articles.Lummy recently obtained the azithromycin granules drug registration certificate issued by the National Medical Products Administration. This medication is suitable for various infections, including bronchitis, pneumonia, skin and soft tissue infections, acute otitis media, sinusitis, pharyngitis, tonsillitis, and genital infections caused by Chlamydia trachomatis
According to the Zhitong Finance APP, Lummy (300006.SZ) announced that it has recently received the Drug Registration Certificate for Azithromycin Granules (Specification: 0.1g calculated as C₃₈H₇₂N₂O₁₂) approved and issued by the National Medical Products Administration.
Azithromycin is a macrolide antibiotic, and Azithromycin Granules are clinically indicated for infections caused by sensitive bacteria, including lower respiratory tract infections such as bronchitis and pneumonia; skin and soft tissue infections; acute otitis media; upper respiratory tract infections such as sinusitis, pharyngitis, and tonsillitis; and uncomplicated genital infections caused by Chlamydia trachomatis